Intensity-modulated radiotherapy with hepatic function reservation using gadoxetate disodium enhanced MRI for hepatocellular carcinoma: the initial results

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000028921

Enrollment

Unknown

Registered

2020-01-07

Start date

2017-01-23

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary liver cancer

Interventions

Case series:Liver function reservation

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Karnofsky score >=70; Aged 18-75 years; Child-pugh score of liver function <=8 points; Patients with primary liver cancer diagnosed histopathologically or cytologically or clinically who are unable to undergo surgery or ablative or refuse surgery; Primary liver cancer with portal thrombus or regional lymph node metastasis; Postoperative gross or microscopic residual; Incomplete hepatic artery chemoembolization; Patients awaiting liver transplantation without liver source.

Exclusion criteria

Exclusion criteria: Karnofsky score <70; Patients with severe hearing impairment; Severe heart, lung, liver and renal insufficiency and inability to tolerate spontaneous breathing control suffocation for 20 s; Cachexia.

Design outcomes

Primary

Measure	Time frame
Dosimetry parameter;	—

Countries

China

Contacts

Public ContactDali Han

Shandong Cancer Hospital and Institute

dalihan_sdch@163.com+86 0531-67626478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026